Open AccessCommunity Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials
Author(s) -
Olubukola T. Idoko,
Aldiouma Diallo,
Samba O. Sow,
Abraham Hodgson,
Adebayo Akinsola,
Bou Diarra,
Fadima Cheick Haidara,
Patrick Ansah,
Beate Kampmann,
Enricke Bouma,
MariePierre Préziosi,
Godwin Enwere
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ596
Subject(s) - medicine , clinical trial , family medicine
The Meningitis Vaccine Project (MVP) was established to address epidemic meningitis as a public health problem in sub-Saharan Africa and, to that end, worked to develop a group A meningococcal conjugate vaccine, PsA-TT.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom